Sen. Mitch McConnell says he’s left rehab, will work from home
“On the advice of my doctors, I’ll maintain an intensive regimen of physical therapy from home during the state work period,” the 84-year-old McConnell said.
Sen. Mitch McConnell says he’s left rehab, will work from home
“On the advice of my doctors, I’ll maintain an intensive regimen of physical therapy from home during the state work period,” the 84-year-old McConnell said.
Sen. Mitch McConnell says he’s left rehab, will work from home
“On the advice of my doctors, I’ll maintain an intensive regimen of physical therapy from home during the state work period,” the 84-year-old McConnell said.
Analysis: Trump treats Fed Chairman Kevin Warsh as an ally. That creates economic risks
Trump’s reported phone calls to the Fed chairman will complicate his efforts to prove he will act independently on inflation and interest rates.
Analysis: Trump treats Fed Chairman Kevin Warsh as an ally. That creates economic risks
Trump’s reported phone calls to the Fed chairman will complicate his efforts to prove he will act independently on inflation and interest rates.
Analysis: Trump treats Fed Chairman Kevin Warsh as an ally. That creates economic risks
Trump’s reported phone calls to the Fed chairman will complicate his efforts to prove he will act independently on inflation and interest rates.
CFRA gets more bullish, hikes S&P 500 year-end target to 8,050
The firm said the revision reflects a confluence of fundamental, technical and historical factors bolstering the market.
Rep. Jim Jordan, House Republicans raise alarms over new South Korean ‘fake news’ law
GOP members of the House Judiciary Committee on Thursday sent a letter to South Korean regulators raising concerns about a law they say will lead to censorship.
Fox won’t renegotiate NFL media rights before current deal expires, CEO Lachlan Murdoch says
Fox has decided not to renegotiate its current TV deal with the NFL until the expiration of the league’s opt-out clause in 2030, said CEO Lachlan Murdoch.
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
